determining benefit of ovarian function suppression: soft trial
Published 6 months ago • 141 plays • Length 7:12Download video MP4
Download video MP3
Similar videos
-
3:11
ovarian function suppression in premenopausal women with breast cancer
-
5:44
breast cancer: adjuvant exemestane combined with ovarian function suppression better than tamoxifen
-
3:37
comparing adjuvant tamoxifen with ovarian function suppression via exomestane to tamoxifen alone
-
6:28
ovarian suppression in metastatic hr breast cancer
-
3:34
partridge: ovarian function suppression in young breast cancer patients
-
2:47
adjuvant endocrine therapy in premenopausal breast cancer: 12-year results from soft
-
1:09
dr. rao on the soft trial in patients with premenopausal breast cancer
-
19:14
ovarian suppression with tamoxifen reduced recurrence in some premenopausal breast cancer cases
-
24:33
session 9: adjuvant endocrine therapy for premenopausal women: risk stratification, type & duration
-
1:14
dr. francis on ovarian suppression for younger women with hr breast cancer
-
2:05
hera: the role of ovarian suppression in hr-positive her2 breast cancer
-
3:12
combination treatments for premenopausal breast cancer: endocrine therapy and ovarian suppression
-
0:53
beth overmoyer discusses role of ovarian suppression in young, high-risk women
-
7:25
ovarian suppression with tamoxifen reduced recurrence for some women with pbc
-
3:25
ovarian suppression and bone management in breast cancer
-
6:46
determining endocrine therapy for premenopausal breast cancer patients: practical considerations
-
6:48
how to use endocrine therapy in premenopausal women with er early breast cancer
-
20:45
the ovaries…to suppress or not? that is the question! presented by jay andersen, md
-
1:28
comment: combining tamoxifen with ovarian suppression reduced recurrence of some breast cancers